Full Press Release Details
For Immediate Release
3M Reports First-Quarter 2020 Results
First-Quarter Highlights:
ST. PAUL, Minn. - April 28, 2020 3M (NYSE: MMM) today reported first-quarter 2020 results.
"In this unprecedented time, I could not be more proud of how our 96,000 people have stepped up to help fight COVID-19, and I thank all 3Mers for their incredible efforts," said Mike Roman, 3M chairman and chief executive officer. "We are attacking the pandemic from all angles, which includes mobilizing all of our resources and rapidly increasing output of critical supplies to healthcare workers and first responders."
"Given the breadth and diversity of our businesses, the financial impact of COVID-19 is varying across 3M," Roman continued. "In the first quarter we saw strong growth in personal safety, as well as in other areas of our portfolio experiencing high demand due to the pandemic. At the same time, we experienced weak demand in several end markets that were more severely impacted by actions taken around the world to slow the pandemic. Looking ahead, 3M is taking action that will help us navigate near-term uncertainty, generate strong cash flow, and lead out of the slowdown by delivering for employees, customers and shareholders."
COVID-19 Response & Business Impact
3M has been aggressively responding to the COVID-19 pandemic given its critical role as a provider of personal protective equipment in the U.S. and across the world. Since the beginning of the year, 3M has continued to:
The COVID-19 pandemic is affecting 3M's businesses in a number of ways. 3M has experienced strong end-market demand, specifically in personal safety, home improvement, general cleaning, food safety and biopharma filtration. At the same time, several other end markets have experienced significant weakness due to social distancing and shelter-in-place mandates. These end markets include oral care, automotive OEM and aftermarket, general industrial, commercial solutions, and stationery and office.
The company is continuing to adapt quickly to the current environment, with a focus on mitigating the near-term impact while positioning 3M's businesses for success coming out of the crisis. Actions being taken include:
Withdrawing Full-Year Outlook
Due to the evolving and uncertain impact of the COVID -19 pandemic, 3M currently is not able to estimate the full duration, magnitude and pace of recovery across its diverse end markets with reasonable accuracy. Therefore, 3M believes it is prudent to withdraw its previously communicated full-year 2020 outlook, which was provided on January 28, 2020. The company will begin reporting monthly sales information starting in May to provide transparency on 3M's ongoing business performance.
First-Quarter Results
Sales were up 2.7 percent year-on-year to $8.1 billion. Organic local-currency sales grew 0.3 percent while acquisitions, net of divestitures, increased sales by 4.2 percent. Foreign currency translation reduced sales by 1.8 percent year-on-year.
Total sales grew 21.0 percent in Health Care and 4.6 percent in Consumer, with declines of 1.0 percent in Safety and Industrial and 5.0 percent in Transportation and Electronics. Organic local-currency sales increased 6.1 percent in Consumer, 2.2 percent in Safety and Industrial and 1.2 percent in Health Care, with a decline of 3.0 percent in Transportation and Electronics.
On a geographic basis, total sales grew 10.1 percent in the Americas, with declines of 2.1 percent in EMEA (Europe, Middle East and Africa) and 5.4 percent in Asia Pacific. Organic local-currency sales increased 4.2 percent in the Americas, with declines of 1.7 percent in EMEA and 4.4 percent in Asia Pacific.
First-quarter GAAP earnings were $2.22 per share, an increase of 47 percent year-on-year, with operating income of $1.7 billion and operating margins of 20.6 percent.
Excluding special items, first-quarter adjusted earnings were $2.16 per share, a decline of 2.7 percent year-on-year, with operating income of $1.7 billion and operating margins of 20.8 percent, as referenced in the "Supplemental Financial Information Non-GAAP Measures" section.
The company's operating cash flow was $1.2 billion with adjusted free cash flow of $0.9 billion contributing to adjusted free cash flow conversion of 74 percent. See the "Supplemental Financial Information Non-GAAP Measures" section for applicable information.
The company paid $847 million in cash dividends to shareholders and repurchased $365 million of its own shares during the quarter.
First-Quarter Business Group Discussion
Safety and Industrial
Transportation and Electronics
3M will conduct an investor teleconference at 9:00 a.m. EDT (8:00 a.m. CDT) today. Investors can access this conference via the following:
Call 800-762-2596 within the U.S. or +1 212-231-2916 outside the U.S. Please join the call at least 10 minutes before the start time.
Go to 3M's Investor Relations website at http://investors.3M.com and click on "Quarterly Earnings."
Call 800-633-8284 within the U.S. or +1 402-977-9140 outside the U.S. (for both U.S. and outside the U.S., the access code is 21930637). The telephone replay will be available until 11:30 a.m. EDT (10:30 a.m. CDT) on May 5, 2020.
Forward-Looking Statements
This news release contains forward-looking information about 3M's financial results and estimates and business prospects that involve substantial risks and uncertainties. You can identify these statements by the use of words such as "anticipate," "estimate," "expect," "aim," "project," "intend," "plan," "believe," "will," "should," "could," "target," "forecast" and other words and terms of similar meaning in connection with any discussion of future operating or financial performance or business plans or prospects. Among the factors that could cause actual results to differ materially are the following: (1) worldwide economic, political, regulatory, capital markets and other external conditions and other factors beyond the Company's control, including natural and other disasters or climate change affecting the operations of the Company or its customers and suppliers; (2) risks related to public health crises such as the global pandemic associated with the coronavirus (COVID-19); (3) liabilities related to certain fluorochemicals, including lawsuits concerning various PFAS-related products and chemistries, and claims and governmental regulatory proceedings and inquiries related to PFAS in a variety of jurisdictions; (4) legal proceedings, including significant developments that could occur in the legal and regulatory proceedings described in the Company's Annual Report on Form 10-K for the year ended Dec. 31, 2019, and any subsequent quarterly reports on Form 10-Q (the "Reports"); (5) competitive conditions and customer preferences; (6) foreign currency exchange rates and fluctuations in those rates; (7) the timing and market acceptance of new product offerings; (8) the availability and cost of purchased components, compounds, raw materials and energy (including oil and natural gas and their derivatives) due to shortages, increased demand or supply interruptions (including those caused by natural and other disasters and other events); (9) unanticipated problems or delays with the phased implementation of a global enterprise resource planning (ERP) system, or security breaches and other disruptions to the Company's information technology infrastructure; (10) the impact of acquisitions, strategic alliances, divestitures and other unusual events resulting from portfolio management actions and other evolving business strategies, and possible organizational restructuring; (11) operational execution, including scenarios where the Company generates fewer productivity improvements than estimated; (12) financial market risks that may affect the Company's funding obligations under defined benefit pension and postretirement plans; and (13) the Company's credit ratings and its cost of capital. Changes in such assumptions or factors could produce significantly different results. A further description of these factors is located in the Reports under "Cautionary Note Concerning Factors That May Affect Future Results" and "Risk Factors" in Part I, Items 1 and 1A (Annual Report) and in Part I, Item 2 and Part II, Item 1A (Quarterly Reports), as updated by applicable Current Reports on Form 8-K. The information contained in this news release is as of the date indicated. The Company assumes no obligation to update any forward-looking statements contained in this news release as a result of new information or future events or developments.
3M Company and Subsidiaries
CONSOLIDATED STATEMENT OF INCOME
(Millions, except per-share amounts)
| Three months ended | ||||||||
| March 31, | ||||||||
| 2020 | 2019 | |||||||
| Net sales | $ | 8,075 | $ | 7,863 | ||||
| Operating expenses | ||||||||
| Cost of sales | 4,109 | 4,310 | ||||||
| Selling, general and administrative expenses | 1,768 | 1,948 | ||||||
| Research, development and related expenses | 537 | 477 | ||||||
| Gain on sale of businesses | (2 | ) | (8 | ) | ||||
| Total operating expenses | 6,412 | 6,727 | ||||||
| Operating income | 1,663 | 1,136 | ||||||
| Other expense (income), net | 96 | 48 | ||||||
| Income before income taxes | 1,567 | 1,088 | ||||||
| Provision for income taxes | 273 | 195 | ||||||
| Net income including noncontrolling interest | $ | 1,294 | $ | 893 | ||||
| Less: Net income attributable to noncontrolling interest | 2 | 2 | ||||||
| Net income attributable to 3M | $ | 1,292 | $ | 891 | ||||
| Weighted average 3M common shares outstanding - basic | 576.8 | 577.5 | ||||||
| Earnings per share attributable to 3M common shareholders - basic | $ | 2.24 | $ | 1.54 | ||||
| Weighted average 3M common shares outstanding - diluted | 581.5 | 588.5 | ||||||
| Earnings per share attributable to 3M common shareholders - diluted | $ | 2.22 | $ | 1.51 |
3M Company and Subsidiaries
CONDENSED CONSOLIDATED BALANCE SHEET
(Dollars in millions)
| March 31, | December 31, | |||||||
| 2020 | 2019 | |||||||
| ASSETS | ||||||||
| Current assets | ||||||||
| Cash and cash equivalents | $ | 4,253 | $ | 2,353 | ||||
| Marketable securities - current | 224 | 98 | ||||||
| Accounts receivable - net | 4,821 | 4,791 | ||||||
| Inventories | 4,217 | 4,134 | ||||||
| Prepaids | 604 | 704 | ||||||
| Other current assets | 971 | 891 | ||||||
| Total current assets | 15,090 | 12,971 | ||||||
| Property, plant and equipment - net | 9,165 | 9,333 | ||||||
| Operating lease right of use assets | 849 | 858 | ||||||
| Goodwill and intangible assets - net | 19,503 | 19,823 | ||||||
| Other assets | 1,605 | 1,674 | ||||||
| Total assets | $ | 46,212 | $ | 44,659 | ||||
| LIABILITIES AND EQUITY | ||||||||
| Current liabilities | ||||||||
| Short-term borrowings and | ||||||||
| current portion of long-term debt | $ | 3,248 | $ | 2,795 | ||||
| Accounts payable | 2,207 | 2,228 | ||||||
| Accrued payroll | 523 | 702 | ||||||
| Accrued income taxes | 136 | 194 | ||||||
| Operating lease liabilities - current | 244 | 247 | ||||||
| Other current liabilities | 2,776 | 3,056 | ||||||
| Total current liabilities | 9,134 | 9,222 | ||||||
| Long-term debt | 19,247 | 17,518 | ||||||
| Other liabilities | 7,622 | 7,793 | ||||||
| Total liabilities | $ | 36,003 | $ | 34,533 | ||||
| Total equity | $ | 10,209 | $ | 10,126 | ||||
| Shares outstanding | ||||||||
| March 31, 2020: 575,196,371 shares | ||||||||
| December 31, 2019: 575,184,835 shares | ||||||||
| Total liabilities and equity | $ | 46,212 | $ | 44,659 |
3M Company and Subsidiaries
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS
(Dollars in millions)
| Three months ended | ||||||||
| March 31, | ||||||||
| 2020 | 2019 | |||||||
| NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES | $ | 1,213 | $ | 1,048 | ||||
| Cash flows from investing activities: | ||||||||
| Purchases of property, plant and equipment | (332 | ) | (391 | ) | ||||
| Acquisitions, net of cash acquired | (25 | ) | (704 | ) | ||||
| Purchases and proceeds from sale or maturities of marketable securities and investments - net | (111 | ) | (142 | ) | ||||
| Proceeds from sale of businesses, net of cash sold | 86 | 6 | ||||||
| Other investing activities | 7 | 6 | ||||||
| NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES | (375 | ) | (1,225 | ) | ||||
| Cash flows from financing activities: | ||||||||
| Change in debt | 2,207 | 1,591 | ||||||
| Purchases of treasury stock | (365 | ) | (701 | ) | ||||
| Proceeds from issuances of treasury stock pursuant to stock option and benefit plans | 149 | 215 | ||||||
| Dividends paid to shareholders | (847 | ) | (830 | ) | ||||
| Other financing activities | (36 | ) | (17 | ) | ||||
| NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES | 1,108 | 258 | ||||||
| Effect of exchange rate changes on cash and cash equivalents | (46 | ) | 4 | |||||
| Net increase (decrease) in cash and cash equivalents | 1,900 | 85 | ||||||
| Cash and cash equivalents at beginning of year | 2,353 | 2,853 | ||||||
| Cash and cash equivalents at end of period | $ | 4,253 | $ | 2,938 |
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES
| (Dollars in millions, except per share amounts) | Operating Income | Operating Income Margin | Income Before Taxes | Provision for Income Taxes | Effective Tax Rate | Net Income Attributable to 3M | Earnings Per Diluted Share | Earnings per diluted share percent change | ||||||||||||||||||||||||
| Q1 2019 GAAP | $ | 1,136 | 14.4 | % | $ | 1,088 | $ | 195 | 17.9 | % | $ | 891 | $ | 1.51 | ||||||||||||||||||
| Adjustments for special items: | ||||||||||||||||||||||||||||||||
| Significant litigation-related charges/benefits | 548 | 548 | 124 | 424 | 0.72 | |||||||||||||||||||||||||||
| (Gain)/loss on sale of businesses | (8 | ) | (8 | ) | (1 | ) | (7 | ) | (0.01 | ) | ||||||||||||||||||||||
| Q1 2019 adjusted amounts (non-GAAP measures) (a) | $ | 1,676 | 21.3 | % | $ | 1,628 | $ | 318 | 19.5 | % | $ | 1,308 | $ | 2.22 | ||||||||||||||||||
| Q1 2020 GAAP | $ | 1,663 | 20.6 | % | $ | 1,567 | $ | 273 | 17.4 | % | $ | 1,292 | $ | 2.22 | 47.0 | % | ||||||||||||||||
| Adjustments for special items: | ||||||||||||||||||||||||||||||||
| Significant litigation-related charges/benefits | 17 | 17 | 56 | (39 | ) | (0.06 | ) | |||||||||||||||||||||||||
| (Gain)/loss on sale of businesses | (2 | ) | (2 | ) | (3 | ) | 1 | - | ||||||||||||||||||||||||
| Q1 2020 adjusted amounts (non-GAAP measures) (a) | $ | 1,678 | 20.8 | % | $ | 1,582 | $ | 326 | 20.6 | % | $ | 1,254 | $ | 2.16 | (2.7 | )% |
| Three months ended March 31, 2020 (dollars in millions) | Safety and Industrial | Transportation and Electronics | Health Care | Consumer | Corporate and Unallocated | Elimination of Dual Credit | Total Company | |||||||||||||||||||||
| Operating income (measure of segment operating performance) | $ | 726 | $ | 484 | $ | 456 | $ | 269 | $ | (156 | ) | $ | (116 | ) | $ | 1,663 | ||||||||||||
| Operating income margin | 24.7 | % | 21.6 | % | 21.7 | % | 21.4 | % | 20.6 | % | ||||||||||||||||||
| Adjustments for special items: | ||||||||||||||||||||||||||||
| Significant litigation-related charges/benefits | $ | 17 | $ | 17 | ||||||||||||||||||||||||
| (Gain)/loss on sale of businesses | $ | (2 | ) | (2 | ) | |||||||||||||||||||||||
| Adjusted operating income (non-GAAP measures) (a) | $ | 726 | $ | 482 | $ | 456 | $ | 269 | $ | (139 | ) | $ | (116 | ) | $ | 1,678 | ||||||||||||
| Adjusted operating income margin (non-GAAP measures) (a) | 24.7 | % | 21.5 | % | 21.7 | % | 21.4 | % | 20.8 | % |
| Three months ended March 31, 2019 (dollars in millions) | Safety and Industrial | Transportation and Electronics | Health Care | Consumer | Corporate and Unallocated | Elimination of Dual Credit | Total Company | |||||||||||||||||||||
| Operating income (measure of segment operating performance) | $ | 637 | $ | 522 | $ | 464 | $ | 235 | $ | (625 | ) | $ | (97 | ) | $ | 1,136 | ||||||||||||
| Operating income margin | 21.5 | % | 22.2 | % | 26.7 | % | 19.6 | % | 14.4 | % | ||||||||||||||||||
| Adjustments for special items: | ||||||||||||||||||||||||||||
| Significant litigation-related charges/benefits | $ | 548 | $ | 548 | ||||||||||||||||||||||||
| (Gain)/loss on sale of businesses | $ | (3 | ) | $ | (5 | ) | (8 | ) | ||||||||||||||||||||
| Adjusted operating income (non-GAAP measures) (a) | $ | 637 | $ | 519 | $ | 459 | $ | 235 | $ | (77 | ) | $ | (97 | ) | $ | 1,676 | ||||||||||||
| Adjusted operating income margin (non-GAAP measures) (a) | 21.5 | % | 22.1 | % | 26.4 | % | 19.6 | % | 21.3 | % |
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES - (CONTINUED)
| Three months ended | ||||||||
| March 31, | ||||||||
| Major GAAP Cash Flow Categories (dollars in millions) | 2020 | 2019 | ||||||
| Net cash provided by (used in) operating activities | $ | 1,213 | $ | 1,048 | ||||
| Net cash provided by (used in) investing activities | (375 | ) | (1,225 | ) | ||||
| Net cash provided by (used in) financing activities | 1,108 | 258 | ||||||
| Adjusted Free Cash Flow (non-GAAP measure) (dollars in millions) | ||||||||
| Net cash provided by (used in) operating activities | $ | 1,213 | $ | 1,048 | ||||
| Purchases of property, plant and equipment | (332 | ) | (391 | ) | ||||
| Free cash flow | $ | 881 | $ | 657 | ||||
| Adjustments for special items: | ||||||||
| Significant litigation-related after-tax payment impacts | $ | 50 | $ | - | ||||
| Divestiture-related restructuring after-tax payment impacts | - | 10 | ||||||
| Adjusted free cash flow (b) | $ | 931 | $ | 667 | ||||
| Net income attributable to 3M | $ | 1,292 | $ | 891 | ||||
| Adjustments for special items: | ||||||||
| Significant litigation-related charges/benefits | (39 | ) | 424 | |||||
| (Gain)/loss on sale of businesses | 1 | (7 | ) | |||||
| Adjusted net income attributable to 3M (a) | $ | 1,254 | $ | 1,308 | ||||
| Adjusted free cash flow conversion (b) | 74 | % | 51 | % |
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES - (CONTINUED)
| Adjusted EBITDA (non-GAAP measure) (c) | Adjusted EBITDA Margin (non-GAAP measure) (c) | |||||||||||||||
| Three months ended March 31, | Three months ended March 31, | |||||||||||||||
| (Dollars in millions) | 2020 | 2019 | 2020 | 2019 | ||||||||||||
| Safety and Industrial | $ | 825 | $ | 737 | 28.1 | % | 24.9 | % | ||||||||
| Transportation and Electronics | 559 | 596 | 25.0 | 25.3 | ||||||||||||
| Health Care | 584 | 513 | 27.8 | 29.5 | ||||||||||||
| Consumer | 285 | 258 | 22.7 | 21.5 | ||||||||||||
| Corporate and Unallocated | (19 | ) | 44 | |||||||||||||
| Elimination of Dual Credit | (116 | ) | (97 | ) | ||||||||||||
| Total Company | $ | 2,118 | $ | 2,051 | 26.2 | % | 26.1 | % |
| Three months ended | ||||||||
| Adjusted EBITDA (non-GAAP measure) (dollars in millions) | March 31, 2020 | March 31, 2019 | ||||||
| Net sales | $ | 8,075 | $ | 7,863 | ||||
| Net income attributable to 3M | 1,292 | 891 | ||||||
| Add/(subtract): | ||||||||
| Net (income)/loss attributable to noncontrolling interest | 2 | 2 | ||||||
| Provision for income taxes | 273 | 195 | ||||||
| Other expense/(income): | ||||||||
| Interest (Income)/expense | 113 | 84 | ||||||
| Pension & OPEB non-service cost (benefit) | (17 | ) | (36 | ) | ||||
| Depreciation and amortization expense | 440 | 375 | ||||||
| Adjustments for special items: | ||||||||
| Significant litigation-related charges/benefits | 17 | 548 | ||||||
| (Gain)/loss on sale of businesses | (2 | ) | (8 | ) | ||||
| Adjusted EBITDA (c) | $ | 2,118 | $ | 2,051 | ||||
| Adjusted EBITDA margin (c) | 26.2 | % | 26.1 | % |
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES - (CONTINUED)
| Adjusted EBITDA (non-GAAP measure) Three months ended March 31, 2020 (dollars in millions) | Safety and Industrial | Transportation and Electronics | Health Care | Consumer | Corporate and Unallocated | Elimination of Dual Credit | Total Company | |||||||||||||||||||||
| Net sales | $ | 2,935 | $ | 2,238 | $ | 2,103 | $ | 1,256 | $ | 1 | $ | (458 | ) | $ | 8,075 | |||||||||||||
| Operating income (measure of segment operating performance) | 726 | 484 | 456 | 269 | (156 | ) | (116 | ) | 1,663 | |||||||||||||||||||
| Add/(subtract): | ||||||||||||||||||||||||||||
| Depreciation and amortization | 99 | 77 | 128 | 16 | 120 | 440 | ||||||||||||||||||||||
| Adjustments for special items: | ||||||||||||||||||||||||||||
| Significant litigation-related charges/benefits | 17 | 17 | ||||||||||||||||||||||||||
| (Gain)/loss on sale of businesses | (2 | ) | (2 | ) | ||||||||||||||||||||||||
| Adjusted EBITDA (non-GAAP measure) (c) | $ | 825 | $ | 559 | $ | 584 | $ | 285 | $ | (19 | ) | $ | (116 | ) | $ | 2,118 | ||||||||||||
| Adjusted EBITDA margin (non-GAAP measure) (c) | 28.1 | % | 25.0 | % | 27.8 | % | 22.7 | % | 26.2 | % |
| Adjusted EBITDA (non-GAAP measure) Three months ended March 31, 2019 (dollars in millions) | Safety and Industrial | Transportation and Electronics | Health Care | Consumer | Corporate and Unallocated | Elimination of Dual Credit | Total Company | |||||||||||||||||||||
| Net sales | $ | 2,963 | $ | 2,355 | $ | 1,738 | $ | 1,200 | $ | 22 | $ | (415 | ) | $ | 7,863 | |||||||||||||
| Operating income (measure of segment operating performance) | 637 | 522 | 464 | 235 | (625 | ) | (97 | ) | 1,136 | |||||||||||||||||||
| Add/(subtract): | ||||||||||||||||||||||||||||
| Depreciation and amortization | 100 | 77 | 54 | 23 | 121 | 375 | ||||||||||||||||||||||
| Adjustments for special items: | ||||||||||||||||||||||||||||
| Significant litigation-related charges/benefits | 548 | 548 | ||||||||||||||||||||||||||
| (Gain)/loss on sale of businesses | (3 | ) | (5 | ) | (8 | ) | ||||||||||||||||||||||
| Adjusted EBITDA (non-GAAP measure) (c) | $ | 737 | $ | 596 | $ | 513 | $ | 258 | $ | 44 | $ | (97 | ) | $ | 2,051 | |||||||||||||
| Adjusted EBITDA margin (non-GAAP measure) (c) | 24.9 | % | 25.3 | % | 29.5 | % | 21.5 | % | 26.1 | % |
| March 31, | December 31, | |||||||
| Net Debt (non-GAAP measure) | 2020 | 2019 | ||||||
| Total debt | $ | 22,495 | $ | 20,313 | ||||
| Less: Cash, cash equivalents and marketable securities | 4,511 | 2,494 | ||||||
| Net debt (d) | $ | 17,984 | $ | 17,819 |
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES - (CONTINUED)
Description of Special Items:
In addition to reporting financial results in accordance with U.S. GAAP, the Company also provides various non-GAAP measures that incorporate adjustments for the impacts of special items. Special items incorporated in the preparation of these non-GAAP measures for the periods presented include the items described below:
Gain/loss from sale of businesses:
Divestiture-related restructuring actions:
Significant litigation-related charges/benefits:
3M Company and Subsidiaries
SALES CHANGE ANALYSIS (e)
| Three months ended March 31, 2020 | ||||||||||||||||
| Europe, | ||||||||||||||||
| Middle | ||||||||||||||||
| Sales Change Analysis | Asia- | East and | World- | |||||||||||||
| By Geographic Area | Americas | Pacific | Africa | Wide | ||||||||||||
| Volume - organic | 3.5% | (3.9)% | (2.8)% | (0.1)% | ||||||||||||
| Price | 0.7 | (0.5 | ) | 1.1 | 0.4 | |||||||||||
| Organic local-currency sales | 4.2 | (4.4 | ) | (1.7 | ) | 0.3 | ||||||||||
| Acquisitions | 7.9 | 0.9 | 3.6 | 4.8 | ||||||||||||
| Divestitures | (0.7 | ) | (0.1 | ) | (1.2 | ) | (0.6 | ) | ||||||||
| Translation | (1.3 | ) | (1.8 | ) | (2.8 | ) | (1.8 | ) | ||||||||
| Total sales change | 10.1 | % | (5.4 | )% | (2.1 | )% | 2.7 | % |
| Three months ended March 31, 2020 | ||||||||||||||||||||
| Worldwide Sales Change | Organic local- | Total sales | ||||||||||||||||||
| By Business Segment | currency sales | Acquisitions | Divestitures | Translation | change | |||||||||||||||
| Safety and Industrial | 2.2 | % | - | % | (1.0 | )% | (2.2 | )% | (1.0 | )% | ||||||||||
| Transportation and Electronics | (3.0 | ) | - | (0.7 | ) | (1.3 | ) | (5.0 | ) | |||||||||||
| Health Care | 1.2 | 21.6 | - | (1.8 | ) | 21.0 | ||||||||||||||
| Consumer | 6.1 | - | - | (1.5 | ) | 4.6 | ||||||||||||||
| Total Company | 0.3 | % | 4.8 | % | (0.6 | )% | (1.8 | )% | 2.7 | % |
3M Company and Subsidiaries
BUSINESS SEGMENTS
Effective in the first quarter of 2020, in a continuing effort to improve the alignment of its businesses around customers and markets, the Company made the following changes:
Continued alignment of customer account activity
Additional actions impacting product line alignments
The financial information presented herein reflects the impact of these changes for all periods presented.